_id
6919e44f3c536f8df2318085
Ticker
AMS.LSE
Name
Advanced Medical Solutions Group plc
Exchange
LSE
Address
Premier Park, Winsford, United Kingdom, CW7 3RT
Country
UK
Sector
Healthcare
Industry
Medical Instruments & Supplies
Currency
GBX
Website
https://www.admedsol.com
Description
Advanced Medical Solutions Group plc, together with its subsidiaries, develops, manufactures, and distributes products for the surgical, woundcare, and wound-closure markets in the United Kingdom, Germany, rest of Europe, the United States, and internationally. The company operates in two segments, Surgical and Woundcare. It offers surgical products, such as tissue adhesives, sutures, haemostats, internal fixation devices, infection control, and internal sealants under LiquiBand, RESORBA, LiquiBandFix8, LIQUIFIX, and Seal-G, Vitalitec, and ActivHeal brand names. The company provides wound care dressings, including silver alginates, alginates, and foams through its ActivHeal brand, as well as under white label. Advanced Medical Solutions Group plc was founded in 1991 and is headquartered in Winsford, the United Kingdom.
Last Close
2195000
Volume
158446
Current Price
215.5
Change
-0.9111617312072893
Last Updated
2025-12-29T14:58:43.890Z
Image
https://logo.clearbit.com/www.admedsol.com
Ipo Date
-
Market Cap
470439616
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.999
Sentiment Sources
1
Rating
4.11
Strong Buy
2
Buy
6
Hold
1
Sell
0
Strong Sell
0
Current Quarter
2025-06-30
Revenue
110769000
Cost Of Revenue
51515000
Gross Profit
59254000
Operating Expenses
48527000
Operating Income
10727000
Interest Expense
2622000
Pretax Income
8463000
Net Income
6205000
Eps
0.028360917239141265
Dividends Per Share
-
Shares Outstanding
216294078
Income Tax Expense
2305000
EBITDA
19803000
Operating Margin
9.6841173974668
Total Other Income Expense Net
-2264000
Cash
19339000
Short Term Investments
-
Receivables
50093000
Inventories
62019000
Total Current Assets
134323000
Property Plant Equipment
46573000
Total Assets
397436000
Payables
32752000
Short Term Debt
12678000
Long Term Debt
59956000
Total Liabilities
140502000
Equity
256242000
Bs_currency_symbol
GBP
Depreciation
10673000
Change In Working Capital
-6051000
Cash From Operations
12783000
Capital Expenditures
2351000
Cash From Investing
-5189000
Cash From Financing
-5174000
Net Change In Cash
2300000
Cf_currency_symbol
-
PE
54.375
PB
184.00027513054067
ROE
2.421539013900922
ROA
1.561257661610926
FCF
10432000
Fcf Percent
0.09417797398189023
Piotroski FScore
4
Health Score
50
Deep Value Investing Score
5
Defensive Investing Score
6.5
Dividend Investing Score
3
Economic Moat Investing Score
6.8
Garp Investing Score
6
Growth Investing Score
5
Momentum Investing Score
5.5
Net Net Investing Score
2.5
Quality Investing Score
5.5
Value Investing Score
3.5
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
110769000
Quarters > 0 > income Statement > cost Of Revenue
51515000
Quarters > 0 > income Statement > gross Profit
59254000
Quarters > 0 > income Statement > operating Expenses
48527000
Quarters > 0 > income Statement > operating Income
10727000
Quarters > 0 > income Statement > interest Expense
2622000
Quarters > 0 > income Statement > pretax Income
8463000
Quarters > 0 > income Statement > net Income
6205000
Quarters > 0 > income Statement > eps
0.028360917239141265
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
218787000
Quarters > 0 > income Statement > income Tax Expense
2305000
Quarters > 0 > income Statement > EBITDA
19803000
Quarters > 0 > income Statement > operating Margin
9.6841173974668
Quarters > 0 > income Statement > total Other Income Expense Net
-2264000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
19339000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
50093000
Quarters > 0 > balance Sheet > inventories
62019000
Quarters > 0 > balance Sheet > total Current Assets
134323000
Quarters > 0 > balance Sheet > property Plant Equipment
46573000
Quarters > 0 > balance Sheet > total Assets
397436000
Quarters > 0 > balance Sheet > payables
32752000
Quarters > 0 > balance Sheet > short Term Debt
12678000
Quarters > 0 > balance Sheet > long Term Debt
59956000
Quarters > 0 > balance Sheet > total Liabilities
140502000
Quarters > 0 > balance Sheet > equity
256242000
Quarters > 0 > balance Sheet > currency_symbol
GBP
Quarters > 0 > cash Flow > net Income
6205000
Quarters > 0 > cash Flow > depreciation
10673000
Quarters > 0 > cash Flow > change In Working Capital
-6051000
Quarters > 0 > cash Flow > cash From Operations
12783000
Quarters > 0 > cash Flow > capital Expenditures
2351000
Quarters > 0 > cash Flow > cash From Investing
-5189000
Quarters > 0 > cash Flow > cash From Financing
-5174000
Quarters > 0 > cash Flow > net Change In Cash
2300000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
0.028360917239141265
Quarters > 0 > ratios > PB
184.00027513054067
Quarters > 0 > ratios > ROE
2.421539013900922
Quarters > 0 > ratios > ROA
1.561257661610926
Quarters > 0 > ratios > FCF
10432000
Quarters > 0 > ratios > Piotroski FScore
4
Quarters > 0 > ratios > fcf Percent
0.09417797398189023
Quarters > 0 > health Score
50
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
109535000
Quarters > 1 > income Statement > cost Of Revenue
60392000
Quarters > 1 > income Statement > gross Profit
49143000
Quarters > 1 > income Statement > operating Expenses
42330000
Quarters > 1 > income Statement > operating Income
6813000
Quarters > 1 > income Statement > interest Expense
3285000
Quarters > 1 > income Statement > pretax Income
4128000
Quarters > 1 > income Statement > net Income
2966000
Quarters > 1 > income Statement > eps
0.013399999974699933
Quarters > 1 > income Statement > dividends Per Share
1638000
Quarters > 1 > income Statement > shares Outstanding
221343284
Quarters > 1 > income Statement > income Tax Expense
1162000
Quarters > 1 > income Statement > EBITDA
18012000
Quarters > 1 > income Statement > operating Margin
6.21992970283471
Quarters > 1 > income Statement > total Other Income Expense Net
-2685000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
17039000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
53684000
Quarters > 1 > balance Sheet > inventories
55259000
Quarters > 1 > balance Sheet > total Current Assets
126278000
Quarters > 1 > balance Sheet > property Plant Equipment
45871000
Quarters > 1 > balance Sheet > total Assets
388996000
Quarters > 1 > balance Sheet > payables
33782000
Quarters > 1 > balance Sheet > short Term Debt
11595000
Quarters > 1 > balance Sheet > long Term Debt
67428000
Quarters > 1 > balance Sheet > total Liabilities
147480000
Quarters > 1 > balance Sheet > equity
240777000
Quarters > 1 > balance Sheet > currency_symbol
GBP
Quarters > 1 > cash Flow > net Income
2966000
Quarters > 1 > cash Flow > depreciation
10599000
Quarters > 1 > cash Flow > change In Working Capital
-4822000
Quarters > 1 > cash Flow > cash From Operations
8899000
Quarters > 1 > cash Flow > capital Expenditures
2511000
Quarters > 1 > cash Flow > cash From Investing
-60644000
Quarters > 1 > cash Flow > cash From Financing
-65378000
Quarters > 1 > cash Flow > net Change In Cash
-117905000
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
0.013399999974699933
Quarters > 1 > ratios > PB
198.10645411314204
Quarters > 1 > ratios > ROE
1.2318452343870054
Quarters > 1 > ratios > ROA
0.7624757066910713
Quarters > 1 > ratios > FCF
6388000
Quarters > 1 > ratios > Piotroski FScore
4
Quarters > 1 > ratios > fcf Percent
0.05831925868443876
Quarters > 1 > health Score
45
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
67986000
Quarters > 2 > income Statement > cost Of Revenue
31091000
Quarters > 2 > income Statement > gross Profit
36895000
Quarters > 2 > income Statement > operating Expenses
32952000
Quarters > 2 > income Statement > operating Income
3641000
Quarters > 2 > income Statement > interest Expense
272000
Quarters > 2 > income Statement > pretax Income
5695000
Quarters > 2 > income Statement > net Income
4176000
Quarters > 2 > income Statement > eps
0.019181568056442316
Quarters > 2 > income Statement > dividends Per Share
3563000
Quarters > 2 > income Statement > shares Outstanding
217709000
Quarters > 2 > income Statement > income Tax Expense
1519000
Quarters > 2 > income Statement > EBITDA
8845000
Quarters > 2 > income Statement > operating Margin
5.355514370605713
Quarters > 2 > income Statement > total Other Income Expense Net
2054000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
134944000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
28996000
Quarters > 2 > balance Sheet > inventories
38564000
Quarters > 2 > balance Sheet > total Current Assets
203001000
Quarters > 2 > balance Sheet > property Plant Equipment
30767000
Quarters > 2 > balance Sheet > total Assets
367785000
Quarters > 2 > balance Sheet > payables
22089000
Quarters > 2 > balance Sheet > short Term Debt
3068000
Quarters > 2 > balance Sheet > long Term Debt
79325000
Quarters > 2 > balance Sheet > total Liabilities
124975000
Quarters > 2 > balance Sheet > equity
242810000
Quarters > 2 > balance Sheet > currency_symbol
GBP
Quarters > 2 > cash Flow > net Income
4176000
Quarters > 2 > cash Flow > depreciation
5703000
Quarters > 2 > cash Flow > change In Working Capital
-6765000
Quarters > 2 > cash Flow > cash From Operations
6962000
Quarters > 2 > cash Flow > capital Expenditures
1546000
Quarters > 2 > cash Flow > cash From Investing
-6670000
Quarters > 2 > cash Flow > cash From Financing
74649000
Quarters > 2 > cash Flow > net Change In Cash
74784000
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
0.019181568056442316
Quarters > 2 > ratios > PB
193.22222931510234
Quarters > 2 > ratios > ROE
1.7198632675754704
Quarters > 2 > ratios > ROA
1.1354459806680535
Quarters > 2 > ratios > FCF
5416000
Quarters > 2 > ratios > Piotroski FScore
4
Quarters > 2 > ratios > fcf Percent
0.0796634601241432
Quarters > 2 > health Score
48
Quarters > 3 > quarter
2023-12-31
Quarters > 3 > income Statement > revenue
63122000
Quarters > 3 > income Statement > cost Of Revenue
28635000
Quarters > 3 > income Statement > gross Profit
34487000
Quarters > 3 > income Statement > operating Expenses
26011000
Quarters > 3 > income Statement > operating Income
8476000
Quarters > 3 > income Statement > interest Expense
644000
Quarters > 3 > income Statement > pretax Income
9389000
Quarters > 3 > income Statement > net Income
6957000
Quarters > 3 > income Statement > eps
0.03183296956718692
Quarters > 3 > income Statement > dividends Per Share
1501000
Quarters > 3 > income Statement > shares Outstanding
218547000
Quarters > 3 > income Statement > income Tax Expense
2432000
Quarters > 3 > income Statement > EBITDA
15658000
Quarters > 3 > income Statement > operating Margin
13.427964893381073
Quarters > 3 > income Statement > total Other Income Expense Net
913000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
60160000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
22291000
Quarters > 3 > balance Sheet > inventories
36046000
Quarters > 3 > balance Sheet > total Current Assets
122322000
Quarters > 3 > balance Sheet > property Plant Equipment
29601000
Quarters > 3 > balance Sheet > total Assets
289171000
Quarters > 3 > balance Sheet > payables
6227000
Quarters > 3 > balance Sheet > short Term Debt
2328000
Quarters > 3 > balance Sheet > long Term Debt
0
Quarters > 3 > balance Sheet > total Liabilities
44969000
Quarters > 3 > balance Sheet > equity
244202000
Quarters > 3 > balance Sheet > currency_symbol
GBP
Quarters > 3 > cash Flow > net Income
6957000
Quarters > 3 > cash Flow > depreciation
5625000
Quarters > 3 > cash Flow > change In Working Capital
-4302000
Quarters > 3 > cash Flow > cash From Operations
8196000
Quarters > 3 > cash Flow > capital Expenditures
1777000
Quarters > 3 > cash Flow > cash From Investing
-7986000
Quarters > 3 > cash Flow > cash From Financing
-9169000
Quarters > 3 > cash Flow > net Change In Cash
-8982000
Quarters > 3 > cash Flow > currency_symbol
GBP
Quarters > 3 > ratios > PE
0.03183296956718692
Quarters > 3 > ratios > PB
192.86033079172162
Quarters > 3 > ratios > ROE
2.8488710166173905
Quarters > 3 > ratios > ROA
2.405842909558704
Quarters > 3 > ratios > FCF
6419000
Quarters > 3 > ratios > Piotroski FScore
4
Quarters > 3 > ratios > fcf Percent
0.10169196159817497
Quarters > 3 > health Score
56
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
177521000
Annuals > 0 > income Statement > cost Of Revenue
84903000
Annuals > 0 > income Statement > gross Profit
82769000
Annuals > 0 > income Statement > operating Expenses
81399000
Annuals > 0 > income Statement > operating Income
10454000
Annuals > 0 > income Statement > interest Expense
3557000
Annuals > 0 > income Statement > pretax Income
9823000
Annuals > 0 > income Statement > net Income
7094000
Annuals > 0 > income Statement > eps
0.032496862087605015
Annuals > 0 > income Statement > dividends Per Share
5201000
Annuals > 0 > income Statement > shares Outstanding
218298000
Annuals > 0 > income Statement > income Tax Expense
2681000
Annuals > 0 > income Statement > EBITDA
29682000
Annuals > 0 > income Statement > operating Margin
5.888880752136367
Annuals > 0 > income Statement > total Other Income Expense Net
-631000
Annuals > 0 > income Statement > currency_symbol
GBP
Annuals > 0 > balance Sheet > cash
17039000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
53684000
Annuals > 0 > balance Sheet > inventories
55259000
Annuals > 0 > balance Sheet > total Current Assets
126278000
Annuals > 0 > balance Sheet > property Plant Equipment
45871000
Annuals > 0 > balance Sheet > total Assets
388996000
Annuals > 0 > balance Sheet > payables
33782000
Annuals > 0 > balance Sheet > short Term Debt
11595000
Annuals > 0 > balance Sheet > long Term Debt
67428000
Annuals > 0 > balance Sheet > total Liabilities
147480000
Annuals > 0 > balance Sheet > equity
240777000
Annuals > 0 > balance Sheet > currency_symbol
GBP
Annuals > 0 > cash Flow > net Income
7094000
Annuals > 0 > cash Flow > depreciation
16302000
Annuals > 0 > cash Flow > change In Working Capital
-6068000
Annuals > 0 > cash Flow > cash From Operations
19489000
Annuals > 0 > cash Flow > capital Expenditures
4057000
Annuals > 0 > cash Flow > cash From Investing
-67149000
Annuals > 0 > cash Flow > cash From Financing
5478000
Annuals > 0 > cash Flow > net Change In Cash
-43121000
Annuals > 0 > cash Flow > currency_symbol
GBP
Annuals > 0 > ratios > PE
0.032496862087605015
Annuals > 0 > ratios > PB
199.46074583535804
Annuals > 0 > ratios > ROE
2.946294704228394
Annuals > 0 > ratios > ROA
1.8236691379859948
Annuals > 0 > ratios > FCF
15432000
Annuals > 0 > ratios > Piotroski FScore
3
Annuals > 0 > ratios > fcf Percent
0.08693056032807386
Annuals > 0 > health Score
49
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
126210000
Annuals > 1 > income Statement > cost Of Revenue
56070000
Annuals > 1 > income Statement > gross Profit
70140000
Annuals > 1 > income Statement > operating Expenses
51258000
Annuals > 1 > income Statement > operating Income
18882000
Annuals > 1 > income Statement > interest Expense
384000
Annuals > 1 > income Statement > pretax Income
21157000
Annuals > 1 > income Statement > net Income
15889000
Annuals > 1 > income Statement > eps
0.07245689478268404
Annuals > 1 > income Statement > dividends Per Share
4775000
Annuals > 1 > income Statement > shares Outstanding
219289000
Annuals > 1 > income Statement > income Tax Expense
5268000
Annuals > 1 > income Statement > EBITDA
31398000
Annuals > 1 > income Statement > operating Margin
14.960779652959353
Annuals > 1 > income Statement > total Other Income Expense Net
2275000
Annuals > 1 > income Statement > currency_symbol
GBP
Annuals > 1 > balance Sheet > cash
60160000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
22291000
Annuals > 1 > balance Sheet > inventories
36046000
Annuals > 1 > balance Sheet > total Current Assets
122322000
Annuals > 1 > balance Sheet > property Plant Equipment
29601000
Annuals > 1 > balance Sheet > total Assets
289171000
Annuals > 1 > balance Sheet > payables
6227000
Annuals > 1 > balance Sheet > short Term Debt
2328000
Annuals > 1 > balance Sheet > long Term Debt
0
Annuals > 1 > balance Sheet > total Liabilities
44969000
Annuals > 1 > balance Sheet > equity
244202000
Annuals > 1 > balance Sheet > currency_symbol
GBP
Annuals > 1 > cash Flow > net Income
15889000
Annuals > 1 > cash Flow > depreciation
10788000
Annuals > 1 > cash Flow > change In Working Capital
-15828000
Annuals > 1 > cash Flow > cash From Operations
12345000
Annuals > 1 > cash Flow > capital Expenditures
9849000
Annuals > 1 > cash Flow > cash From Investing
-20265000
Annuals > 1 > cash Flow > cash From Financing
-13618000
Annuals > 1 > cash Flow > net Change In Cash
-22102000
Annuals > 1 > cash Flow > currency_symbol
GBP
Annuals > 1 > ratios > PE
0.07245689478268404
Annuals > 1 > ratios > PB
197.55603967207477
Annuals > 1 > ratios > ROE
6.506498718274216
Annuals > 1 > ratios > ROA
5.49467270231109
Annuals > 1 > ratios > FCF
2496000
Annuals > 1 > ratios > Piotroski FScore
3
Annuals > 1 > ratios > fcf Percent
0.0197765628714048
Annuals > 1 > health Score
53
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
124330000
Annuals > 2 > income Statement > cost Of Revenue
55709000
Annuals > 2 > income Statement > gross Profit
68621000
Annuals > 2 > income Statement > operating Expenses
48526000
Annuals > 2 > income Statement > operating Income
24890000
Annuals > 2 > income Statement > interest Expense
638000
Annuals > 2 > income Statement > pretax Income
25910000
Annuals > 2 > income Statement > net Income
20406000
Annuals > 2 > income Statement > eps
0.09297387928795658
Annuals > 2 > income Statement > dividends Per Share
4341000
Annuals > 2 > income Statement > shares Outstanding
219481000
Annuals > 2 > income Statement > income Tax Expense
5504000
Annuals > 2 > income Statement > EBITDA
34939000
Annuals > 2 > income Statement > operating Margin
20.019303466580872
Annuals > 2 > income Statement > total Other Income Expense Net
1020000
Annuals > 2 > income Statement > currency_symbol
GBP
Annuals > 2 > balance Sheet > cash
82262000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
21553000
Annuals > 2 > balance Sheet > inventories
27911000
Annuals > 2 > balance Sheet > total Current Assets
131910000
Annuals > 2 > balance Sheet > property Plant Equipment
29015000
Annuals > 2 > balance Sheet > total Assets
281094000
Annuals > 2 > balance Sheet > payables
6416000
Annuals > 2 > balance Sheet > short Term Debt
2118000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
44472000
Annuals > 2 > balance Sheet > equity
236622000
Annuals > 2 > balance Sheet > currency_symbol
GBP
Annuals > 2 > cash Flow > net Income
24890000
Annuals > 2 > cash Flow > depreciation
8844000
Annuals > 2 > cash Flow > change In Working Capital
-5972000
Annuals > 2 > cash Flow > cash From Operations
26877000
Annuals > 2 > cash Flow > capital Expenditures
9964000
Annuals > 2 > cash Flow > cash From Investing
-11879000
Annuals > 2 > cash Flow > cash From Financing
-6321000
Annuals > 2 > cash Flow > net Change In Cash
9297000
Annuals > 2 > cash Flow > currency_symbol
GBP
Annuals > 2 > ratios > PE
0.09297387928795658
Annuals > 2 > ratios > PB
204.06310486767924
Annuals > 2 > ratios > ROE
8.623881126860562
Annuals > 2 > ratios > ROA
7.259493265597985
Annuals > 2 > ratios > FCF
16913000
Annuals > 2 > ratios > Piotroski FScore
4
Annuals > 2 > ratios > fcf Percent
0.1360331376176305
Annuals > 2 > health Score
69
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
108601000
Annuals > 3 > income Statement > cost Of Revenue
52486000
Annuals > 3 > income Statement > gross Profit
56115000
Annuals > 3 > income Statement > operating Expenses
38072000
Annuals > 3 > income Statement > operating Income
22998000
Annuals > 3 > income Statement > interest Expense
1098000
Annuals > 3 > income Statement > pretax Income
21984000
Annuals > 3 > income Statement > net Income
17481000
Annuals > 3 > income Statement > eps
0.08007347282787937
Annuals > 3 > income Statement > dividends Per Share
3845000
Annuals > 3 > income Statement > shares Outstanding
218312000
Annuals > 3 > income Statement > income Tax Expense
4503000
Annuals > 3 > income Statement > EBITDA
31549000
Annuals > 3 > income Statement > operating Margin
21.176600583788364
Annuals > 3 > income Statement > total Other Income Expense Net
-1014000
Annuals > 3 > income Statement > currency_symbol
GBP
Annuals > 3 > balance Sheet > cash
72965000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
21016000
Annuals > 3 > balance Sheet > inventories
19300000
Annuals > 3 > balance Sheet > total Current Assets
114973000
Annuals > 3 > balance Sheet > property Plant Equipment
27441000
Annuals > 3 > balance Sheet > total Assets
249509000
Annuals > 3 > balance Sheet > payables
4878000
Annuals > 3 > balance Sheet > short Term Debt
256000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
36832000
Annuals > 3 > balance Sheet > equity
212677000
Annuals > 3 > balance Sheet > currency_symbol
GBP
Annuals > 3 > cash Flow > net Income
22998000
Annuals > 3 > cash Flow > depreciation
8848000
Annuals > 3 > cash Flow > change In Working Capital
1277000
Annuals > 3 > cash Flow > cash From Operations
31025000
Annuals > 3 > cash Flow > capital Expenditures
6463000
Annuals > 3 > cash Flow > cash From Investing
-6326000
Annuals > 3 > cash Flow > cash From Financing
-5105000
Annuals > 3 > cash Flow > net Change In Cash
19136000
Annuals > 3 > cash Flow > currency_symbol
GBP
Annuals > 3 > ratios > PE
0.08007347282787937
Annuals > 3 > ratios > PB
225.82902711623728
Annuals > 3 > ratios > ROE
8.219506575699299
Annuals > 3 > ratios > ROA
7.006160098433323
Annuals > 3 > ratios > FCF
24562000
Annuals > 3 > ratios > Piotroski FScore
4
Annuals > 3 > ratios > fcf Percent
0.22616734652535428
Annuals > 3 > health Score
75
Valuation > metrics > PE
54.375
Valuation > metrics > PB
184.00027513054067
Valuation > final Score
1
Valuation > verdict
3075.4% Overvalued
Profitability > metrics > ROE
2.421539013900922
Profitability > metrics > ROA
4.619462042985937
Profitability > metrics > Net Margin
0.05601747781418989
Profitability > final Score
27
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.5483176060130658
Risk > metrics > Interest Coverage
4.091151792524791
Risk > final Score
64
Risk > verdict
High
Liquidity > metrics > Current Ratio
2.9567026194144836
Liquidity > metrics > Quick Ratio
1.5915474356152322
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
40
Prev Valuations > 1
40
Prev Valuations > 2
40
Prev Profitabilities > 0
14
Prev Profitabilities > 1
19
Prev Profitabilities > 2
39
Prev Risks > 0
56
Prev Risks > 1
88
Prev Risks > 2
100
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:59:45.676Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-17
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Advanced Medical Solutions Group plc, together with its subsidiaries, develops, manufactures, and distributes products for the surgical, woundcare, and wound-closure markets in the United Kingdom, Germany, rest of Europe, the United States, and internationally. The company operates in two segments, Surgical and Woundcare. It offers surgical products, such as tissue adhesives, sutures, haemostats, internal fixation devices, infection control, and internal sealants under LiquiBand, RESORBA, LiquiBandFix8, LIQUIFIX, and Seal-G, Vitalitec, and ActivHeal brand names. The company provides wound care dressings, including silver alginates, alginates, and foams through its ActivHeal brand, as well as under white label. Advanced Medical Solutions Group plc was founded in 1991 and is headquartered in Winsford, the United Kingdom.
Stock Price
GBp 0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A3 UK Stocks Estimated To Be Trading At Up To 48% Discount simplywall.st
Read more →Showing 2 of 10
(Last Updated 2025-06-30)
Rating:
BUY
$
Analyst Picks
Strong Buy
2
Buy
6
Hold
1
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-06-30)
Health Score
Price to Earnings Ratio (P/E)
-
Very Low
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Medium
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Advanced Medical Solutions Group plc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
—
Date
—
EPS Actual
—
EPS Estimate
—
EPS Difference
—
Surprise Percent
undefined%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
£ 0
Cost Of Revenue
£ 0
Gross Profit
£ 0
Operating Expenses
£ 0
Operating Income
£ 0
Interest Expense
£ 0
Pretax Income
£ 0
Net Income
£ 0
Income Tax Expense
£ 0
EBITDA
£ 0
Total Other Income Expense Net
£ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
£ 0
Short Term Investments
£ 0
Receivables
£ 0
Inventories
£ 0
Total Current Assets
£ 0
Property Plant Equipment
£ 0
Total Assets
£ 0
Payables
£ 0
Short Term Debt
£ 0
Long Term Debt
£ 0
Total Liabilities
£ 0
Equity
£ 0
(Last Updated 2025-06-30)
Net Income
£ 0
Depreciation
£ 0
Change In Working Capital
£ 0
Cash From Operations
£ 0
Capital Expenditures
£ 0
Cash From Investing
£ 0
Cash From Financing
£ 0
Net Change In Cash
£ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.